Late on Wednesday, the World Health Organisation issued an alert that four “contaminated” medicines manufactured by Maiden Pharmaceuticals – an Indian company -- have been “potentially linked” to the death of 66 children in the Gambia. The WHO and the Indian government have launched investigations.
In this podcast, Deputy Editor Jyothi Datta puts things in context. Listen in!
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.